Found: 5
Select item for more details and to access through your institution.
Cessation of Ciprofloxacin Prophylaxis in Hemato-Oncology Patients.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
Managing HIV and Hodgkin Lymphoma in the Twenty-first century.
- Published in:
- Current Hematologic Malignancy Reports, 2014, v. 9, n. 3, p. 227, doi. 10.1007/s11899-014-0215-4
- By:
- Publication type:
- Article
Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID‐19: disease control as an important factor relative to recent chemotherapy or anti‐CD20 therapy.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 892, doi. 10.1111/bjh.17937
- By:
- Publication type:
- Article
Reduced intensity allogeneic hematopoietic stem cell transplantation is a safe and effective treatment option in high‐risk myeloma patients – a single centre experience.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 2, p. 420, doi. 10.1111/bjh.17379
- By:
- Publication type:
- Article
Clinical outcome of coronavirus disease 2019 in haemato‐oncology patients.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 2, p. e64, doi. 10.1111/bjh.16852
- By:
- Publication type:
- Article